These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27076285)

  • 1. Siderophore biosynthesis coordinately modulated the virulence-associated interactive metabolome of uropathogenic Escherichia coli and human urine.
    Su Q; Guan T; Lv H
    Sci Rep; 2016 Apr; 6():24099. PubMed ID: 27076285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siderophore Biosynthesis Governs the Virulence of Uropathogenic Escherichia coli by Coordinately Modulating the Differential Metabolism.
    Su Q; Guan T; He Y; Lv H
    J Proteome Res; 2016 Apr; 15(4):1323-32. PubMed ID: 26954697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferric Citrate Uptake Is a Virulence Factor in Uropathogenic Escherichia coli.
    Frick-Cheng AE; Sintsova A; Smith SN; Pirani A; Snitkin ES; Mobley HLT
    mBio; 2022 Jun; 13(3):e0103522. PubMed ID: 35546538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic analysis of siderophore cheater mutants reveals metabolic costs of expression in uropathogenic Escherichia coli.
    Lv H; Hung CS; Henderson JP
    J Proteome Res; 2014 Mar; 13(3):1397-404. PubMed ID: 24476533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Omic' Approaches to Study Uropathogenic Escherichia coli Virulence.
    Lo AW; Moriel DG; Phan MD; Schulz BL; Kidd TJ; Beatson SA; Schembri MA
    Trends Microbiol; 2017 Sep; 25(9):729-740. PubMed ID: 28550944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uropathogenic Escherichia coli wield enterobactin-derived catabolites as siderophores.
    Zou Z; Robinson JI; Steinberg LK; Henderson JP
    J Biol Chem; 2024 Jan; 300(1):105554. PubMed ID: 38072063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics Assay Identified a Novel Virulence-Associated Siderophore Encoded by the High-Pathogenicity Island in Uropathogenic Escherichia coli.
    Xu G; Guo H; Lv H
    J Proteome Res; 2019 May; 18(5):2331-2336. PubMed ID: 30994357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small RNA RyhB contributes to siderophore production and virulence of uropathogenic Escherichia coli.
    Porcheron G; Habib R; Houle S; Caza M; Lépine F; Daigle F; Massé E; Dozois CM
    Infect Immun; 2014 Dec; 82(12):5056-68. PubMed ID: 25245805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.
    Reitzer L; Zimmern P
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31619395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence factors of uropathogenic E. coli and their interaction with the host.
    Lüthje P; Brauner A
    Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siderophore production by uropathogenic Escherichia coli.
    Vagrali MA
    Indian J Pathol Microbiol; 2009; 52(1):126-7. PubMed ID: 19136808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The iron hand of uropathogenic Escherichia coli: the role of transition metal control in virulence.
    Robinson AE; Heffernan JR; Henderson JP
    Future Microbiol; 2018 Jun; 13(7):745-756. PubMed ID: 29870278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotyping of the Yersinia high-pathogenicity island that regulates central carbon metabolism.
    Yan L; Nie W; Lv H
    Analyst; 2015 May; 140(10):3356-61. PubMed ID: 25870861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
    Yun KW; Kim HY; Park HK; Kim W; Lim IS
    J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments: Siderophore production by uropathogenic Escherichia coli.
    Gokarn K
    Indian J Pathol Microbiol; 2010; 53(3):570. PubMed ID: 20699532
    [No Abstract]   [Full Text] [Related]  

  • 16. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of virulence factors and phylogenetic characterization of uropathogenic Escherichia coli causing urinary tract infection in patients with and without diabetes mellitus.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    Trans R Soc Trop Med Hyg; 2015 Dec; 109(12):769-74. PubMed ID: 26567223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siderophore-Microcins in
    Massip C; Oswald E
    Front Cell Infect Microbiol; 2020; 10():381. PubMed ID: 32974212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uropathogenic Escherichia coli Express Type 1 Fimbriae Only in Surface Adherent Populations Under Physiological Growth Conditions.
    Stærk K; Khandige S; Kolmos HJ; Møller-Jensen J; Andersen TE
    J Infect Dis; 2016 Feb; 213(3):386-94. PubMed ID: 26290608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
    Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA
    Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.